Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples